Ives SJ, Andtbacka RH, Kwon SH, Shiu YT, Ruan T, Noyes RD, Zhang QJ, Symons JD, Richardson RS. Heat and ␣1-adrenergic responsiveness in human skeletal muscle feed arteries: the role of nitric oxide. J Appl Physiol 113: 1690 -1698 , 2012 . First published October 4, 2012 doi:10.1152/japplphysiol.00955.2012.-Increased local temperature exerts a sympatholytic effect on human skeletal muscle feed arteries. We hypothesized that this attenuated ␣1-adrenergic receptor responsiveness may be due to a temperatureinduced increase in nitric oxide (NO) bioavailability, thereby reducing the impact of the ␣1-adrenergic receptor agonist phenylephrine (PE). Thirteen human skeletal muscle feed arteries were harvested, and wire myography was used to generate PE concentration-response curves at 37°C and 39°C, with and without the NO synthase (NOS) inhibitor
INCREASES IN TEMPERATURE have been documented to significantly reduce ␣ 1 -adrenergic receptor-mediated vasoconstriction (8, 24, 36, 42, 46, 52, 70) . However, it is unclear from these studies whether these thermal effects are due to changes in receptor-agonist affinity, an effect on postreceptor signal integration, or altered inherent smooth muscle function. Prior work in animals revealed increased or decreased smooth muscle function with heating (41, 47, 69, 70) , which, in addition to other factors, may depend on vessel location and the specific temperature induced by heating (69) . Adding to this work, our group (24) recently demonstrated that inherent smooth muscle function in human feed arteries, as assessed by the response to KCl, was unchanged with heating to 39°C. Therefore, in human feed arteries, which are thought to be important in the distribution of skeletal muscle blood flow (26, 72) , it appears that heat exerts an effect specific to receptor-mediated vasoconstriction, but whether this could also be the result of antagonistic vasodilation cannot be ruled out.
The pluripotent molecule nitric oxide (NO) exerts a significant vasodilatory effect and is normally produced by the endothelium during exercise through shear stress stimulation of endothelial NO synthase (eNOS) or catalyzed by neuronal NO synthase (NOS) on the sarcolemma (4, 55, 65, 68) . NO may directly reduce the impact of sympathetic nerves innervating smooth muscle (58) or relax the smooth muscle by stimulating guanylyl cyclase, providing opposition to vasoconstriction (5, 9, 18, 48) . As it appears that sympathetic discharge remains intact during exercise (45) and warming (10) , a reduction in postjunctional receptor responsiveness to sympathetic activity is most likely responsible for the attenuated vasoconstriction under such conditions (12, 21, 42) . Therefore, increased bioavailability of NO is a plausible mechanism by which heat affects vasodilation. Nevertheless, in vivo work in humans investigating the role of NO during exercise, a by-product of which is heat, has been inconclusive, revealing little effect on exercise hyperemia (49, 61) or the response to exogenous sympathomimetics (14) with eNOS blockade alone. Specific to heat, prior work revealed that local, but not whole body, heating increases skeletal muscle blood flow (20, 28) and opposes ␣-receptor-mediated vasoconstriction. However, the mechanism responsible for these observations remains elusive.
Using an in vivo sinoaortic-deafferented rodent model, Kregel and colleagues (35) revealed that eNOS inhibition by N G -nitro-L-arginine methyl ester significantly attenuated the reduction in hindlimb resistance during passive heating, implicating NO as a factor responsible for heat-induced vasodilation. Using an in vitro approach, Harris et al. (19) demonstrated that prior heat shock (42°C) in isolated rat aortas resulted in a significantly reduced vasocontractile response to phenylephrine (PE), which was effectively restored with NOS blockade. Finally, in cell culture, heat exposure increased mRNA expres-sion, protein expression, and activity of eNOS in endothelial cells, suggesting heat as a stimulus for the NO pathway (19) . However, translational work is needed to determine if the aforementioned observations remain true in human arteries that are likely capable of producing vascular resistance (26) and if such effects hold true when the arteries are acutely exposed to temperatures within a physiological range that is attainable during exercise (54) and, thus, may contribute to functional sympatholysis (50, 73) .
Consequently, with a combination of in vitro vessel studies, molecular approaches, and an endothelial cell culture model, the goal of this study was to determine the mechanistic role of NO in the heat-induced reduction in ␣ 1 -receptor-mediated vasocontraction in human skeletal muscle feed arteries. Specifically, we hypothesized that increasing temperature will attenuate ␣ 1 -receptor-mediated vasocontraction and that effective blockade of NOS will 1) partially restore vasocontraction, 2) increase eNOS, but not alter ␣ 1 -receptor protein expression in arteries, and 3) sensitize the endothelial cell response to shear stress, resulting in greater eNOS activation and NO production.
METHODS

Vessel Experiments
Subjects and general procedures. Thirteen heterogeneous subjects (5 men and 8 women, 36 -85 yr old) agreed to have their vessels harvested for during surgery and used in this study (Table 1) . Although medical conditions and medications were noted, there were no exclusion criteria based on this information. None of the subjects included in the study had received chemotherapy, as this was a contraindication for surgery. All protocols were approved by the Institutional Review Boards of the University of Utah and the Salt Lake City Veterans Affairs Medical Center, and written informed consent was obtained from all subjects.
Vessel harvest and preparation. Human skeletal muscle feed arteries from the axillary and inguinal regions were obtained during melanoma-related node dissection surgeries at the Huntsman Cancer Hospital. Patients were anesthetized using a standard protocol including propofol, fentanyl, benzodiazepines, and succinylcholine. After removal of sentinel lymph nodes or lymph node dissection, skeletal muscle feed arteries in the axillary (e.g., serratus anterior or latissimus dorsi) or inguinal (e.g., hip adductors or quadriceps femoris) regions were identified and classified as feed arteries on the basis of entry into a muscle bed, structure, color, and pulsatile bleed pattern. The vessels were ligated, excised, and immediately placed in pH-balanced (pH 7.35-7.45) cold (ϳ4°C) physiological saline solution (PSS) and brought to the laboratory within 15 min of harvesting. The feed arteries were dissected (e.g., to remove perivascular adipose tissue) and cut into rings under a stereomicroscope in cold (ϳ4°C) normal PSS (NPSS; in mM: 125 NaCl, 4.7 KCl, 1.2 KH 2PO4, 1.2 MgSO4, 2.5 CaCl2, 18 NaHCO3, 0.026 Na2EDTA, and 11.2 glucose). All NPSS and drugs were prepared fresh daily. The NPSS was continuously aerated with carbogen gas (95% O2-5% CO2), and pH was monitored at regular intervals and maintained at 7.35-7.45 (Orion 3 Star, Thermo Scientific, Waltham, MA). Each artery was dissected into four rings (ϳ2 mm long) and mounted in wire myography chambers (700 MO, DMT Systems, Aarhus, Denmark). Once the artery was mounted, the vessel chamber continued to be aerated with the same carbogen gas mixture, and chamber NPSS was exchanged at 10-min intervals, except during cumulative drug concentration responses. Vessel length and diameter were measured using a calibrated micrometer eyepiece and reported in micrometers. Vessel chambers were gradually warmed to 37°C over a 30-min equilibration period prior to protocol commencement (Fig. 1) .
Vessel function protocols. All vessels underwent length-tension procedures to determine the length at which the vessels produced the greatest tension in response to a single concentration (100 mM) of KCl (L max) (62, 71) . Lmax was operationally defined as Ͻ10% improvement in developed tension in response to 100 mM KCl (24) . Vessel function was characterized using KCl (10 -100 mM), sodium nitroprusside (SNP, 10 Ϫ9 -10 Ϫ4 log M), phenylephrine (PE, 10 Ϫ9 -10 Ϫ3 log M), and ACh (10 Ϫ7 -10 Ϫ3 log M) concentration-response curves (CRCs) to determine non-receptor-and receptor-mediated vasocontraction and vasorelaxation. For normalization of vasocontraction data to the individual maximal response, as described elsewhere (25, 27, 32, 71) , all vasocontractile responses are expressed as a percentage of the individual maximal response to 100 mM KCl (%KCl max) obtained during the length-tension protocol, which typically yields the greatest tension development (unpublished observations). All vasodilation responses are expressed as percent relaxation toward basal tone from a PE-induced precontraction, approximating 60 -70% of the maximal response to PE (PE max).
To determine the role of NO in mediating the attenuation of PE-induced vasocontraction with heating, the temperature in two of four myograph chambers was increased to 39°C, and the NOS inhibitor N G -monomethyl-L-arginine (L-NMMA, 10 Ϫ3 log M) (63) was added to one of these chambers prior to the PE CRCs. The other two chambers remained at 37°C to serve as controls, and L-NMMA was added to one of these chambers (Fig. 1) . L-NMMA-induced NOS inhibition was assessed during the ACh (endothelium-dependent) and SNP (endothelium-independent) CRCs. Each experimental protocol was separated by 30 min. Vessel-tension data were acquired at 4 Hz using an analog-to-digital data acquisition system (Biopac Systems, Goleta, CA) allowing real-time monitoring and off-line analyses.
Western blot analysis. To further elucidate the role of eNOS or the ␣ 1-adrenergic receptor as a component of the mechanism by which heating alters vasocontraction in human skeletal muscle feed arteries, we performed experiments to examine if protein content changes with heating. Specifically, in a subset of feed arteries, with tissue remaining after dissection for wire myography (n ϭ 4), two vessel rings from each artery were placed in 2-ml CryoVials containing pH-balanced (ϳ7.4), well-oxygenated NPSS. One vessel ring was exposed to 37°C and the other to 39°C for 60 min to determine if heating itself would alter eNOS or ␣ 1-adrenergic receptor protein expression. Vessels were then snap-frozen in liquid nitrogen for later analysis. The pH of the NPSS was measured again to confirm proper pH during the heat exposure and was found to be unchanged.
The snap-frozen feed arteries were thawed on ice, homogenized in 200 l of ice-cold homogenization buffer containing a protease and phosphatase inhibitor cocktail (Sigma, St. Louis, MO), and centrifuged for 15 min at 13,800 g at 4°C. The supernatant was collected, and total protein concentrations were determined using the bicinchoninic acid method with BSA as a standard (Pierce Chemical, Rockford, IL). Supernatants were stored at Ϫ80°C. Standard Western blot methods were used to probe membranes with primary antibodies for ␣ 1-adrenergic receptor (ab3462, Abcam, Cambridge, MA), eNOS (610296, BD Transduction, Franklin Lakes, NJ), and GAPDH (ab9485, Abcam) and visualized via enhanced chemiluminescence (Pierce detection kit) using a digital imaging system (Chemidoc XRS Imager, Bio-Rad Laboratories, Hercules, CA). Membranes were stained with Coomassie blue (Bio-Rad Laboratories) for a loading/ transfer control. Proteins of interest were normalized to the loading control (GAPDH); then values at 39°C were normalized as a percentage of the 37°C control.
Endothelial Cell Experiments
To better isolate the effects of temperature on endothelial cells and eNOS, we adopted an endothelial cell culture model to measure eNOS protein expression, eNOS activation (phosphorylation at Ser 1177 ), and NO production [total nitrate ϩ nitrite (NOx)] as a result of exposure to the following conditions: 37°C static (no shear stress), 37°C ϩ shear stress, 39°C static, 39°C ϩ shear stress. The cells were exposed to their respective conditions for 60 min. Each experiment was performed in triplicate (n ϭ 3).
Cell culture. Cells and cell culture reagents were obtained from Invitrogen (Grand Island, NY) unless otherwise indicated. Bovine aortic endothelial cells (BAECs) were cultured in flasks in DMEM supplemented with 10% FBS. Cell culture was maintained in a humidified 5% CO 2-95% air incubator at 37°C. All experiments were conducted with cultures of passage 3-6. Flow experiments. Cells were removed from the flask using trypsin-EDTA, placed on fibronectin (5 g/cm 2 )-coated glass slides, and exposed to constant fluid shear stress of 15 dyn/cm 2 for 1 h using a recirculating, parallel-plate flow-chamber system, as previously described (60) . The shear stress of 15 dyn/cm 2 is within the physiological range in major human arteries and has been documented to activate endothelial cell signal transduction and induce the expression of several genes in vitro (7) . During the flow experiments, the system was kept at 37°C or 39°C in a constant-temperature hood, and the circulation medium (DMEM supplemented with 10% FBS) was ventilated with a humidified gas mixture of 95% room air-5% CO2. All shear stress experiments included static controls (i.e., endothelial cells cultured on slides not exposed to shear stress). Upon completion of the flow experiments, cells were scraped and lysed in 150 l of cold (4°C) lysis buffer, centrifuged at 5,000 g for 5 min, and immediately stored at Ϫ80°C until Western blot analysis.
eNOS and NOx analysis. Samples were subsequently probed for eNOS phosphorylation at Ser 1177 (catalog no. 9570, Cell Signaling, Boston, MA), a well-described activation site on eNOS (6, 13), total eNOS (catalog no. 610296, BD Transduction), and GAPDH (ab9485, Abcam), as a loading control by Western blot analysis. Proteins of interest were normalized to the loading control prior to analysis. Additionally, to estimate NO production, NOx (the stable metabolite of NO) was determined using endothelial cell supernatant. Samples were ultrafiltrated using a 10-kDa molecular weight cutoff filter (Millipore, Billerica, MA) and centrifuged (5,000 g) at 4°C for 1 h. NOx was measured using a standard colorimetric nitrate reductase/ Griess reaction assay (Cayman Chemical, Ann Arbor, MI). The interand intra-assay coefficients of variation for this assay are ϳ3%, with a detection limit of 2.5 M. Both assays (Western blot and NOx) were performed in duplicate.
Statistical Analysis
Statistical analysis was performed using commercially available software (SPSS version 16, SPSS, Chicago, IL). A repeated-measures ANOVA was utilized to determine if there were differences in developed tension responses to cumulative concentrations of PE between conditions (37°C, 39°C, 37°C ϩ L-NMMA, and 39°C ϩ L-NMMA). Because of potential differences in kinetics, the individual PEmax was identified in each condition and analyzed using a one-way ANOVA. Significant differences were followed up with Tukey's honestly significant difference test for pair-wise comparisons. Nonparametric t-tests were used to determine the effect of heating on eNOS and ␣ 1-adrenergic receptor protein expression in arteries and if differences existed in endothelial cell responses to shear stress. The level of statistical significance was set at ␣ ϭ 0.05. Values are means Ϯ SE.
RESULTS
Vessel Experiments
Subject characteristics. Subject characteristics are documented in Table 1 . The subjects were varied in terms of demographics (e.g., age) but, as a whole, should be considered relatively healthy, given the relatively normal blood pressure and blood analysis results (Table 1) , with the group average within the normal range for each assessment.
Vessel characteristics. The average internal diameter for the feed arteries was 888 Ϯ 75 m, and the average length was Basal tone between conditions was significantly different, with heating resulting in an increased basal tone (P Ͻ 0.05), which was significantly augmented by NOS blockade using L-NMMA in normothermic and heated conditions. However, although statistically significant, these changes represent only ϳ1-3% KCl max . There was a significant (P Ͻ 0.05) difference between conditions with regard to PE-induced vasocontraction at 37°C and 39°C with and without L-NMMA ( Fig. 2A) . Post hoc pair-wise comparisons indicate that heating significantly attenuated the response to PE at the highest concentration (10 Ϫ3 log M) of PE (37 Ϯ 10% KCl max at 39°C, P Ͻ 0.05); however, NOS blockade at 39°C evoked a vasocontractile response similar to that at 37°C (79 Ϯ 27 and 83 Ϯ 30% KCl max , respectively; Fig. 2A ). NOS blockade also tended to increase the response to PE at 37°C (103 Ϯ 30% KCl max ; Fig. 2A) ; however, in this paradigm, the effect of the blockade was not statistically significant (P Ͼ 0.05).
Because of potential differences in the concentration that elicits the peak response to PE, a maximal response to PE across the full CRC was identified on an individual basis. The individual maximal PE responses were lower (P Ͻ 0.01) at 39°C (39 Ϯ 10% KCl max ) than at 37°C (84 Ϯ 30% KCl max ); however, NOS blockade restored vasocontraction at 39°C to equal that at 37°C (80 Ϯ 27% KCl max ; Fig. 2B ). NOS blockade also tended to enhance PE-induced vasocontraction at 37°C (107 Ϯ 31% KCl max ), but not to the same extent as the heated condition (Fig. 2B) , and this effect of the blockade was not statistically significant (P Ͼ 0.05).
Western blot analysis of arteries. Western blot analysis revealed no significant difference in ␣ 1 -adrenergic receptor protein expression ( Fig. 3A ; P Ͼ 0.05) or GAPDH (data not shown) across temperatures. However, for vessel rings incubated at 39°C, eNOS protein was significantly upregulated compared with vessel rings at 37°C ( Fig. 3B ; P Ͻ 0.05).
Endothelial Cell Experiments
Exposure of BAECs to shear stress in normothermic conditions did not change total eNOS (data not shown) but did increase phosphorylation of eNOS at Ser 1177 ( Fig. 4A ; P Ͻ 0.05) and tended to increase NO production, as estimated by NOx levels (Fig. 4C ), but this latter observation did not achieve statistical significance. Neither heating nor shear stress had an effect on GAPDH expression (data not shown). Heating significantly reduced eNOS phosphorylation in the static condition when normalized to total eNOS (Fig. 4A) , but not when normalized to GAPDH (data not shown); as eNOS protein tended to increase with heating, this did not achieve significance (data not shown). Heating the endothelial cells to 39°C resulted in shear stress-induced eNOS phosphorylation when values were normalized to the loading control (GAPDH; data not shown) or to total eNOS (Fig. 4A ). This resulted in significantly increased NO production, as estimated by NOx levels (Fig. 4C) . While there was a tendency for greater eNOS with heating, in static and shear conditions, this effect did not achieve significance (P ϭ 0.20). There was also no difference based on temperature in the shear-induced elevation in total eNOS (data not shown). Expression of the data as shear stress-induced change (⌬ ϭ shear Ϫ static condition responses) at 37°C or 39°C revealed that heating resulted in significantly greater phosphorylation of eNOS and NOx production (Fig. 4 , B and D) than in the normothermic condition, suggesting that heating may sensitize shear stress-induced eNOS phosphorylation and NO production.
DISCUSSION
The main finding of this study was that heating attenuated the vascular sensitivity to ␣ 1 -adrenergic stimulation in human skeletal muscle feed arteries and that this effect was reversed by NOS blockade. At the molecular level, heating induced a significant increase in arterial eNOS protein expression but no change in ␣ 1 -adrenergic receptor protein expression. A cell (BAEC)-based approach was used to demonstrate that heating sensitized the endothelial cell NO response to shear stress, resulting in greater eNOS activation and, subsequently, enhanced production of NO. Taken together, these data support the hypothesis that heat-induced reductions in ␣ 1 -adrenergic receptor-mediated vasocontraction are, at least in part, due to an increase in NO bioavailability in human skeletal muscle feed arteries, likely a key site of muscle blood flow regulation. Such findings highlight the important role that heat may play in enhancing the vascular responsiveness to shear-induced increases in NO production and, conceivably, functional sympatholysis as a by-product of increased metabolic demand.
Heat and Vascular Reactivity
The mechanisms responsible for functional sympatholysis (50, 73) remain poorly understood, in part due to the complex nature of in vivo physiology and redundant mechanisms. While many variables (e.g., K ϩ , ATP, and H ϩ ) are likely partially responsible for functional sympatholysis, a local elevation in temperature is also a potential candidate (3, 33) . Specifically, the exercise-induced increase in skeletal muscle metabolism releases copious amounts of heat as a by-product, with as much as 65% of the energy from metabolic pathways being lost as heat (37) . Indeed, as a consequence, intramuscular temperature has been documented to increase to ϳ39°C during moderateintensity exercise (39, 54) . Thus, specific to heat, using a variety of reductionist approaches, previous studies demonstrated a reduction in mean arterial pressure, an increase in muscle blood flow (20) , and/or a reduction in vasoconstrictor responsiveness during passive heating in vivo (12, 35, 36, 42, 51, 53, 59) , despite potentially significant increases in sympathetic nervous system activity (11, 34) and intact baroreflex sensitivity (12, 43) . A common explanation for these results is a reduction in postjunctional receptor responsiveness. Using an in vitro approach, we (24) and others (8, 19, 46, 69, 70) documented a sympatholytic effect of heating on sympathetically mediated vasocontraction. Thus the sympatholytic effect of heating has been suggested to be specific to receptormediated vasocontraction, as previous studies have indicated that direct depolarization of the smooth muscle was not, in fact, altered by heating (24, 36) . In contrast, in the current study, our observation of an increase in basal tone with heating provides some evidence of enhanced basal smooth muscle function. However, the magnitude of this effect was very small compared with the effect on vasocontraction observed during the PE CRC (Ͻ1% of the difference in maximum PE-induced developed tension between conditions). Thus, at rest, under passive tension, heating does result in a general increase in smooth muscle activity, which can enhance basal tone (41) . However, in contrast to a previous study (41) , this augmentation of basal smooth muscle activity does not carry over to active tension development using an ␣ 1 -receptor agonist or KCl (24) . Thus the suppressant effect of heating to 39°C on ␣ 1 -adrenergic receptor-mediated vasocontraction in the present study (Fig. 2) does not appear to be the result of altered basal tone or smooth muscle function. This conclusion is in agreement with the seminal studies of Vanhoutte and colleagues (69, 70) , who concluded that the effects of temperature on venocontraction induced by agonists or direct electrical stimulation were not due to a direct thermal effect on the "contractile machinery" itself. 
Temperature and NO
The NOS enzyme has been determined to be a major promoter of exercise hyperemia, in part, by counteracting sympathetic nervous system activity (4, 15, 55-57, 64 -66) . The dependency of enzymes on temperature is a well-described phenomenon; thus it is not surprising that NOS activity may also be potentiated by heat (19, 35) . Furthermore, eNOS has been demonstrated to be temperature-dependent, with heating increasing NO and inducing vasodilation, which opposes vasoconstriction (19, 29, 30, 35) , findings that are qualitatively the same as those of the current study (Fig. 2) . However, not all studies have demonstrated an NO-dependent vasodilation and reduction in vasoconstrictor response with heating (40, 53) or during exercise (14) . However, the complex processes and redundant mechanisms in vivo, coupled with methodological considerations, may have confounded previous results and left the impact of NO on vasoconstriction, during exercise or heat stress, somewhat equivocal. This contrasts with the current in vitro study, which demonstrated a relatively clear role of NO in the heat-induced attenuation of receptor-mediated vasoconstriction.
In a comprehensive study, Harris et al. (19) investigated the role of heat shock in the regulation of eNOS in a rodent model. These researchers found that heating not only increased heat shock protein 90 expression, but also increased the eNOS protein signal (mRNA), eNOS protein expression, eNOS activation/phosphorylation, and eNOS functional activity. Therefore, it is highly likely that the increased vasodilator function associated with heating reduces the functional consequence of vasoconstrictors. Indeed, Harris et al. found that heat stress reduced the maximal response to PE, an effect that was reversed with NOS blockade. In agreement with the work of Harris et al., the current study reveals that heating increases eNOS protein (Fig. 3) in whole artery homogenate and is suggestive of greater NOS activity with heating, as evidenced by the greater effect of L-NMMA at 39°C than at 37°C, indicating heightened basal NO bioavailability with heat (Fig.  2) . Using a physiologically relevant cell culture/shear model, we have highlighted the fact that exposure of BAECs to shear stress with acute mild heating, such as the heating that could be achieved during exercise, sensitizes these endothelial cells to shear stress. Specifically, eNOS activation during mild heating Temperature, Sympatholysis, and Nitric Oxide • Ives SJ et al. was greater than in the normothermic condition and resulted in greater production of NOx, an estimate of NO (Fig. 4) . Not only do these results have implications for the regulation of skeletal muscle blood flow during exercise or under heat stress, but our findings support the notion that heating could be used as an adjuvant therapy to increase endothelial NO production in populations with limited exercise capacity and higher risk of vascular dysfunction and cardiovascular disease (1, 22, 23) .
Sympatholysis as a "Tug-of-War"
Historically, functional sympatholysis has been viewed under an analytical lens that infers, as the name implies, a "lysing" of sympathetic activity. Indeed, researchers have focused on the concept of reduced vasoconstrictor responsiveness, rather than a change in smooth muscle signal integration. However, the current data emphasize the potential for increased vasodilatory capacity, rather than reduced vasoconstrictor potency, as a bona fide mechanism responsible for reduced ␣ 1 -adrenergic receptor-mediated vasoconstriction with heat, resulting in the concept of a tug-of-war between vasodilators and vasoconstrictors (31) . This vasodilatory component of the process is likely postjunctional, as muscle sympathetic nerve activity and norepinephrine spillover remain intact during exercise (38, 44) . Specific to heat, in a rodent model, increased muscle sympathetic nerve activity did not prevent a fall in hindlimb resistance during passive heating (35) , but blockade of the eNOS enzyme significantly attenuated this vasodilation, implicating NO and, more accurately, heat-induced changes in NO in the sympatholysis. Also, in support of this concept, Shibasaki et al. (59) demonstrated that NO attenuated norepinephrine-induced cutaneous vasoconstriction in vivo in humans. Moreover, various studies in animals have documented a NO-dependent abatement of sympathetic vasoconstriction (65, 67) . Thus, on the basis of such prior work and the current data, it appears that a component of functional sympatholysis is likely an increased abundance of vasodilators, such as NO, rather than simply an insufficiency of vasoconstrictors, which "tips the balance" in favor of vasodilation and subsequent hyperemia in the tug-of-war between vasodilators and vasoconstrictors during exercise.
Limitations
The subjects who took part in this study were certainly heterogeneous in terms of age, gender, and health (Table 1) . Additionally, vessels were harvested in proximity to sentinel node regions in individuals receiving prophylactic surgical treatment for melanoma, the site of which is typically distal to the nodes. However, most lymph nodes from these patients were found to be negative for melanoma metastasis via histology and some via polymerase chain reaction analysis. In support of this, the lactate dehydrogenase values [considered to be a clinical indicator of metastasis in melanoma patients (2)] were within the normal range for all subjects (Table 1) . Also, the novel approach of harvesting these human arteries during axial and inguinal surgeries yielded the expected receptor-and non-receptor-mediated vasocontraction and vasorelaxation characteristics, suggestive of somewhat uniform and normal physiology, despite potential pathology and rather varied origin. Therefore, despite a heterogeneous group of subjects and potential pathology, the fact that temperature and NOS blockade exhibited a common effect across subjects speaks to the robust nature of this response as it relates to the regulation of sympathetically mediated vasocontraction in humans. Specifically, in this population, independent of age, gender, or disease status, heating significantly attenuates ␣ 1 -adrenergic receptormediated vasocontraction, and this phenomenon can be modulated by attenuating NO bioavailability by NOS inhibition. It is likely that larger sample sizes are required to detect differences in age, gender, or disease status, and the current study may have been inadequately powered to detect these differences. Thus, addressing these issues with true conviction requires further investigation. Also, it would be interesting to see if heat exerts similar effects on nonadrenergic pathways such as the purinergic (33) or neuropeptide Y (17) vasoconstrictor responses, and this also warrants further study. Finally, although the endothelial cell experiments were performed with a widely accepted endothelial cell line (BAECs), it must be acknowledged that these are nonprimate cells and, thus, may respond in a manner different from human cells.
Conclusion
This study provides evidence that heat increases NO bioavailability and opposes ␣ 1 -adrenergic receptor-mediated vasocontraction in human skeletal muscle feed arteries. Additionally, heat sensitizes endothelial cells to shear stress, resulting in greater eNOS activation and NO production. Thus, with the capacity of feed arteries to regulate skeletal muscle blood flow, heat, as a consequence of muscle contraction, has the potential to stimulate eNOS, override ␣ 1 -adrenergic receptor-mediated vasoconstriction, and increase skeletal muscle blood flow.
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